-
Targanta Therapeutics Corporation (Nasdaq: TARG) today announced that oritavancin, the Company's investigational antibiotic therapy for the treatment of complicated skin and skin structure infections (cSSSI) caused by gram-positive pathogens, including methicillin resistant Staphylococcus aureus (MRSA), received a mixed review from the United States Food and Drug Administration's (FDA) Anti-Infective Drugs ...
-
A recent clinical study found that patients experienced nearly a 70% reduction in pain when MPM Medical Inc.'s Regenecare HA® hydrogel was used prior to and during the changing of their wound dressings. The finding comes at a time when a cross-section of American thought leaders are calling the lack ...
-
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has begun recruitment for its Phase 2 clinical trial of the Company's lead oncology agent PV-10 at a sixth major center located at the California Pacific Medical Center, in San Francisco, CA. David Minor, M.D. will serve ...
-
Michelson Diagnostics has announced that it will demonstrate its prototype multi-beam Optical Coherence Tomography (OCT) probe at the BIOS Exhibition at SPIE Photonics West, San Jose, 24-25th January 2009 (Stand 8731). More than one variant of the new probe will be launched later in 2009, including a dermal version (with ...
-
In a cross-Tasman first, Australia and New Zealand have collaborated with a joint approach to the development of treatment guidelines for cancer, to be launched today (19/11) at the Clinical Oncological Society of Australia Annual Scientific Meeting in Sydney....
-
Nicotinamide (VitB3), a vitamin found in common foods like meats, nuts, grains and cereals, may provide the next advance in skin cancer prevention, according to new research from the University of Sydney. Presenting the results of a trial to the Clinical Oncological Society of Australia's Annual Scientific Meeting today (19 ...
-
Genentech, Inc. (NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform dermatologists and neurologists of a 2nd case of progressive multifocal leukoencephalopathy (PML) which resulted in the death of a 73-year old woman who had received Raptiva® (efalizumab) for approximately four years for treatment ...
-
Cracking, chaffing, dry patches, and itchiness - all are unpleasant symptoms of dry and irritated skin that often comes with winter. As temperatures drop, the wind howls, and humidity levels hit an all-year low, our skin requires extra attention and care to stay healthy....
-
Bargains on consumer goods and services may be designed to encourage spending in tough economic times, however when related to cosmetic injections like Restylane, Juvederm or Botox, the multi-specialty Physicians Coalition for Injectable Safety warns that discounts raise a red flag....
-
According to a study published in the November issue of Archives of Dermatology, an effective treatment for plaque-type psoriasis can be found in traditional Chinese medicine. Yin-Ku Lin, M.D. (Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan) and colleagues found that an ointment based on the dark-blue, plant-based ...
-
A study published in the November issue of Archives of Dermatology seeks to determine which beachgoers would benefit from targeted interventions to reduce skin cancer risk by identifying sun-protection practices and risk profiles. In the past 30 years, the Unites States has seen a rapid increase in the incidence of ...
-
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the Company and the U.S. Food and Drug Administration (FDA) have reached agreement on the design of a phase 3 registration trial for thymalfasin as a potential treatment for stage IV melanoma. Based on the FDA's review, the agency agrees that the ...
-
Researchers report promising results for the viability of a portable, handheld device using a specialized light technique that may enhance the differential diagnosis of non-melanoma skin cancers, inflamed scar tissue and normal skin in vivo....
-
Teens continue to put themselves at unnecessary risk of skin cancer by spending excessive time in the sun and forgetting to protect themselves, according to new Cancer Council research. Findings from the Cancer Council's National Sun Protection Survey released today show teens spend an average of two hours (1hr 51mins) ...
-
PREMARIN® (conjugated estrogens) Vaginal Cream 0.5 g has been approved by the U.S. Food and Drug Administration (FDA) for a new indication and a new less frequent twice-weekly dosing regimen to treat moderate to severe postmenopausal dyspareunia (painful sexual intercourse) announced Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE)....
-
In what is believed to be the first time in the United States, a nerve transfer was performed on a paraplegic to relieve life-threatening pressure ulcers - a common side effect associated with wheelchair-bound patients. The surgery took place on November 11, 2008, at Monmouth County Medical Center, and was ...
-
Scientists have discovered a way to potentially restore colour to white hair, new research in the British Journal of Dermatology will reveal this month. A number of skin disorders cause the hair to fall out, and when it re-grows, it is often white. For many patients, this is almost as ...
-
She's travelled between Brisbane and Paris to better understand skin cancer, and now UQ PhD student Marina Kvaskoff has been awarded a top French prize for her research. Ms Kvaskoff, from St Lucia, is one of only 10 academics to win a 2008 L'Oreal France-UNESCO For Women in Science Award, ...
-
In the emotional rollercoaster of life, sometimes the "down" periods have long-lasting effects on more than just our mood. In fact, numerous studies link factors that impact our emotional well-being such as stress, depression and anxiety to an increase in skin, hair or nail problems. Now, dermatologists are advising patients ...
-
Based on current estimates, 8,420 people are expected to die from melanoma this year. In an effort to reverse this sobering trend, dermatologists and the scientific community alike are continually developing new diagnostics, refining detection guidelines and providing patients with the tools they need to properly examine their own skin ...
